menu
    • menu

    Company profile for Eikon Therapeutics

    NEW Drugs in Dev: 7
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eikon Therapeutics is a biopharmaceutical company pioneering the integration of advanced engineering and high-resolution microscopy to observe protein dynamics in living cells. This innovative approach accelerates the discovery of novel treatments for life-threatening diseases. Founded in 2019 and headquartered in Hayward, California, Eikon's multidisciplinary team is dedicated to transforming drug discovery and development. ...
    Eikon Therapeutics is a biopharmaceutical company pioneering the integration of advanced engineering and high-resolution microscopy to observe protein dynamics in living cells. This innovative approach accelerates the discovery of novel treatments for life-threatening diseases. Founded in 2019 and headquartered in Hayward, California, Eikon's multidisciplinary team is dedicated to transforming drug discovery and development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eikon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3929 Point Eden Way, Hayward, CA 94545
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eikontx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veradermics, Eikon Eye Public Market Debut As IPO Tap Opens
    Veradermics, Eikon Eye Public Market Debut As IPO Tap Opens

    12 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/veradermics-eikon-eye-public-market-debut-as-ipo-tap-opens

    BIOSPACE
    12 Jan 2026
    Share Share
    Eikon Plans IPO To Bankroll Clutch Of Clinical Cancer Drugs
    Eikon Plans IPO To Bankroll Clutch Of Clinical Cancer Drugs

    12 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eikon-next-line-ipo-funds-set-bankroll-clutch-clinical-cancer-drugs

    FIERCE BIOTECH
    12 Jan 2026
    Share Share
    Eikon Therapeutics Elects David W. Meline to Board of Directors
    Eikon Therapeutics Elects David W. Meline to Board of Directors

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202492256/en/Eikon-Therapeutics-Announces-the-Election-of-David-W.-Meline-to-its-Board-of-Directors

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    Eikon to Present Ph2 EIK1001 Data in NSCLC at ESMO 2025
    Eikon to Present Ph2 EIK1001 Data in NSCLC at ESMO 2025

    15 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251015335117/en/Eikon-Therapeutics-to-Present-New-Phase-2-Data-on-EIK1001-in-First-Line-Non-Small-Cell-Lung-Cancer-at-ESMO-2025

    BUSINESSWIRE
    15 Oct 2025
    Share Share
    Eikon Therapeutics to Share Data at 2025 ASCO Annual Meeting
    Eikon Therapeutics to Share Data at 2025 ASCO Annual Meeting

    29 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250529330808/en/Eikon-Therapeutics-to-Share-Clinical-Data-and-Program-Updates-at-the-2025-ASCO-Annual-Meeting

    BUSINESSWIRE
    29 May 2025
    Share Share
    Eikon blames US cuts for 15% staff reduction
    Eikon blames US cuts for 15% staff reduction

    23 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/eikon-blames-us-funding-cuts-15-layoffs-centered-research-tools-business

    FIERCE BIOTECH
    23 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search